This work introduces novel 3-difluoromethyl-benzoxaboroles with improved bioactivity, suggesting new antimicrobial applications.
Benzoxaboroles, prominent scaffolds in medicinal chemistry, are typically modified on the benzene ring. In contrast, functionalization of the oxaborol ring is less common and often challenging. Indeed, 3-hydroxy-benzoxaboroles are virtually impossible to isolate due to their tautomeric equilibrium with the carbonyl form. In this work, we introduce a novel class of stereodefined 3-difluoromethyl-benzoxaboroles. The replacement of the hydroxy group with -CHF₂ preserves stability while promoting bioactivity, owing to the lipophilic H-bond donor properties of the latter.
No takes yet. Share an insight, caveat, or question.
Dimasi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: